These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 8162353)

  • 1. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxin as a therapeutic target in septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):35-43. PubMed ID: 8162352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current prospects for the treatment of clinical sepsis.
    Suffredini AF
    Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.
    Barriere SL; Guglielmo BJ
    Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic effects of endotoxin.
    Zivot JB; Hoffman WD
    New Horiz; 1995 May; 3(2):267-75. PubMed ID: 7583168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of endotoxin-induced vascular permeability by monoclonal antibodies against lipopolysaccharide determinants.
    Rubin RM; Noland J; Rosenbaum JT
    Circ Shock; 1992 Mar; 36(3):217-23. PubMed ID: 1377103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
    Gorelick KJ; Chmel H
    Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiendotoxin therapy in sepsis.
    Colletti RC; Dew RB; Goulart AE
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):345-54. PubMed ID: 8398040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock.
    Maury E; Blanchard HS; Chauvin P; Guglielminotti J; Alzieu M; Guidet B; Offenstadt G
    J Crit Care; 2003 Jun; 18(2):115-20. PubMed ID: 12800122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.
    Opal SM; Yu RL
    Drugs; 1998 Apr; 55(4):497-508. PubMed ID: 9561340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological intervention in endotoxin shock.
    Ziegler EJ
    Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
    [No Abstract]   [Full Text] [Related]  

  • 14. Endotoxin as a drug target.
    Opal SM; Glück T
    Crit Care Med; 2003 Jan; 31(1 Suppl):S57-64. PubMed ID: 12544978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting endotoxin in the treatment of sepsis.
    Rachoin JS; Schorr CA; Dellinger RP
    Subcell Biochem; 2010; 53():323-38. PubMed ID: 20593274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-endotoxin antibodies and other inhibitors of endotoxin.
    Zanetti G; Glauser MP; Baumgartner JD
    New Horiz; 1993 Feb; 1(1):110-9. PubMed ID: 7922383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapies for sepsis. Emerging therapies for sepsis and septic shock.
    Abraham E
    West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195
    [No Abstract]   [Full Text] [Related]  

  • 18. Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies.
    Cornelissen JJ; Schellekens JF; Kraaijeveld CA; Verhoef J
    Neth J Med; 1991 Oct; 39(3-4):170-6. PubMed ID: 1791879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal antibodies in the treatment of sepsis and septic shock].
    Torrabadella de Reynoso P; Salgado Remigio A; Peracaula Picart R
    Med Clin (Barc); 1992 Dec; 99(20):784-92. PubMed ID: 1460952
    [No Abstract]   [Full Text] [Related]  

  • 20. [The application of molecular biology to anti-endotoxin therapies].
    Someya T; Sasaki K; Hirata K
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):523-6. PubMed ID: 12884777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.